Cecilia Furlong
Stock Analyst at Morgan Stanley
(0)
# 4154
Out of 5,240 analysts
207
Total ratings
42.31%
Success rate
-6.97%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Nevro | Downgrades: Underweight | 9 4 | 3.67 | 8.99% | 9 | Dec 2, 2024 | |
Intuitive Surgical | Upgrades: Overweight | 522 650 | 538.11 | 20.79% | 13 | Dec 2, 2024 | |
Sight Sciences | Maintains: Equal-Weight | 7 5 | 3.15 | 58.73% | 15 | Nov 11, 2024 | |
Embecta | Maintains: Underweight | 13 12 | 20.11 | -40.33% | 12 | Jul 15, 2024 | |
iRhythm Technologies | Maintains: Overweight | 135 130 | 99.01 | 31.3% | 15 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 130 120 | 104.65 | 14.67% | 11 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 75 95 | 62.57 | 51.83% | 12 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 104 98 | 85.13 | 15.12% | 9 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 76 69 | n/a | n/a | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 83 83 | 79.31 | 4.65% | 10 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 1 | n/a | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 78 85 | 82.68 | 2.81% | 9 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 224 291 | n/a | n/a | 6 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 15 | 29.71 | -49.51% | 4 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 325 343 | 267.3 | 28.32% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 14 | 6.85 | 104.38% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 44 48 | 30.61 | 56.81% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 95 102 | 71.02 | 43.62% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 56 58 | 95.55 | -39.3% | 16 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 18 20 | 17.23 | 16.08% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 117 131 | 79.23 | 65.34% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 117 133 | 113.03 | 17.67% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 235 380 | n/a | n/a | 2 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 270 220 | 362.71 | -39.35% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 383 378 | 178.99 | 111.18% | 2 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 29 25 | n/a | n/a | 3 | Jan 7, 2022 |